# EDGAR Filing Document

**Accession Number:** 0001230239
**File Stem:** 0000902664-25-003539
**Filing Date:** 2025-8
**Character Count:** 13203
**Document Hash:** a869f327900a76cce270e196db4f6d70
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000902664-25-003539.hdr.sgml**: 20250813

**ACCESSION NUMBER**: 0000902664-25-003539

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250813

**DATE AS OF CHANGE**: 20250813

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hinge Health, Inc.
- **CENTRAL INDEX KEY:** 0001673743
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 811884841
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-95135
- **FILM NUMBER:** 251208894

**BUSINESS ADDRESS:**
- **STREET 1:** 455 MARKET STREET
- **STREET 2:** 7TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** 415-689-8429

**MAIL ADDRESS:**
- **STREET 1:** 455 MARKET STREET
- **STREET 2:** 7TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ALKEON CAPITAL MANAGEMENT LLC
- **CENTRAL INDEX KEY:** 0001230239

**ORGANIZATION NAME:**
- **EIN:** 134200093
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 350 MADISON AVENUE
- **STREET 2:** 20TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2127166576

**MAIL ADDRESS:**
- **STREET 1:** 350 MADISON AVENUE
- **STREET 2:** 20TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

## Exhibit 99.1

**EXHIBIT 99.1**

**JOINT ACQUISITION STATEMENT<br> PURSUANT TO RULE 13d-1(k)**

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

DATED: August 13, 2025

---

| | |
|:---|:---|
| ALKEON CAPITAL MANAGEMENT, LLC | ALKEON CAPITAL MANAGEMENT, LLC |
| By: | /s/ Jennifer Shufro |
| Name: Jennifer Shufro | Name: Jennifer Shufro |
| Title: Compliance Officer | Title: Compliance Officer |
| &nbsp;&nbsp;/ s/ Panayotis D. Sparaggis | &nbsp;&nbsp;/ s/ Panayotis D. Sparaggis |
| &nbsp;&nbsp;PANAYOTIS D. SPARAGGIS | &nbsp;&nbsp;PANAYOTIS D. SPARAGGIS |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** Hinge Health, Inc.

**Title of Class of Securities:** Class A Common Stock, par value $0.00001 per share

**CUSIP Number:** 433313103

**Date of Event Which Requires Filing of this Statement:** 06/30/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [x] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Alkeon Capital Management LLC | Names of Reporting Persons<br>Alkeon Capital Management LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1591104.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1591104.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1591104.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1591104.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.7% | Percent of Class Represented by Amount in Row (9)<br>5.7% |
| 12. | Type of Reporting Person (See Instructions)<br>IA, OO | Type of Reporting Person (See Instructions)<br>IA, OO |

**Comment for Type of Reporting Person:** Includes 1,215,093 shares of Class A Common Stock (as defined in Item 2(a)) issuable upon conversion of Class B Common Stock (as defined in Item 2(a)).

---

| 1. | Names of Reporting Persons<br>Panayotis D. Sparaggis | Names of Reporting Persons<br>Panayotis D. Sparaggis |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1591104.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1591104.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1591104.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1591104.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.7% | Percent of Class Represented by Amount in Row (9)<br>5.7% |
| 12. | Type of Reporting Person (See Instructions)<br>HC, IN | Type of Reporting Person (See Instructions)<br>HC, IN |

**Comment for Type of Reporting Person:** Includes 1,215,093 shares of Class A Common Stock issuable upon conversion of Class B Common Stock.

---

**Item 1(a). Name of Issuer:**
Hinge Health, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
455 Market Street, Suite 700, San Francisco, CA 94105

**Item 2(a). Name of Person Filing:**
This statement is filed by:

(i) Alkeon Capital Management LLC ("Alkeon"), a Delaware limited liability company and the investment manager to certain funds (the "Alkeon Funds"), with respect to the shares of Class A Common Stock, par value $0.00001 per share ("Class A Common Stock") of Hinge Health, Inc., a Delaware corporation (the "Company") directly held by, and the shares of Class A Common Stock issuable upon conversion of the shares the Company's Class B Common Stock, par value $0.00001 per share (the "Class B Common Stock") directly held by, the Alkeon Funds; and

(ii) Panayotis D. Sparaggis ("Mr. Sparaggis"), the Founder and Managing Director of Alkeon, with respect to the shares of Class A Common Stock directly held by, and the shares of Class A Common Stock issuable upon conversion of the shares of Class B Common Stock directly held by, the Alkeon Funds.

The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."

The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the securities reported herein.

**Item 2(b). Address of Principal Business Office:**
The address of the business office of each of the Reporting Persons is 350 Madison Avenue, 20th Floor, New York, NY  10017.

**Item 2(c). Citizenship:**
The Investment Manager is a Delaware limited liability company. Mr. Sparaggis is a citizen of the United States.

**Item 2(d). Title of Class of Securities:**
Class A Common Stock, par value $0.00001 per share

**Item 2(e). CUSIP Number:**
433313103

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 26,799,441 shares of Class A Common Stock outstanding as reported in the Company's Prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on May 23, 2025, and in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 23, 2025, after giving effect to the completion of the offering and the full exercise of the underwriters' over-allotment option, all as described therein, and assumes the conversion of the shares of Class B Common Stock held by the Alkeon Funds.

**(b) Percent of class:**

5.7%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

**(ii) Shared power to vote or to direct the vote:**

The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

**(iii) Sole power to dispose or to direct the disposition of:**

The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

**(iv) Shared power to dispose or to direct the disposition of:**

The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

See Item 2(a). The Alkeon Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, shares of Class A Common Stock.

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Alkeon Capital Management LLC**

**Date:** 08/13/2025

**By:** /s/ Jennifer Shufro

**Name & Title:** Jennifer Shufro, Compliance Officer

**Panayotis D. Sparaggis**

**Date:** 08/13/2025

**By:** /s/ Panayotis D. Sparaggis

**Name & Title:** Panayotis D. Sparaggis, Individually